Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Reza Mohebi, M.D.

Title
Institution
Department
Address
Phone
Profile Picture

Biography
Mount Sinai Medical Center, NYMD06/2021Internal Medicine Residency

Overview

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Mohebi R, Liu Y, van Kimmenade R, Gaggin HK, Murphy SP, Januzzi JL. Inflammation across universal definition of heart failure stages: the CASABLANCA study. Eur J Heart Fail. 2022 Nov 17. PMID: 36394549.
    Citations:    Fields:    
  2. Mohebi R, Liu Y, Felker GM, Prescott MF, Piña IL, Butler J, Ward JH, Solomon SD, Januzzi JL. Prediction of Left Ventricular Ejection Fraction Change Following Treatment With Sacubitril/Valsartan. JACC Heart Fail. 2023 Jan; 11(1):44-54. PMID: 36599549.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  3. Mohebi R, Liu Y, Piña IL, Prescott MF, Butler J, Felker GM, Ward JH, Solomon SD, Januzzi JL. Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol. 2022 10 18; 80(16):1529-1541. PMID: 36229089.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  4. Mohebi R, van Kimmenade R, McCarthy CP, Magaret CA, Barnes G, Rhyne RF, Gaggin HK, Januzzi JL. Performance of a multi-biomarker panel for prediction of cardiovascular event in patients with chronic kidney disease. Int J Cardiol. 2023 Jan 15; 371:402-405. PMID: 36202172.
    Citations:    Fields:    Translation:Humans
  5. Mohebi R, Liu Y, Felker GM, Prescott MF, Ward JH, Piña IL, Butler J, Solomon SD, Januzzi JL. Heart Failure Duration and Mechanistic Efficacy of Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction. J Card Fail. 2022 Dec; 28(12):1673-1682. PMID: 36122820.
    Citations:    Fields:    Translation:Humans
  6. Mohebi R, Chen C, Ibrahim NE, McCarthy CP, Gaggin HK, Singer DE, Hyle EP, Wasfy JH, Januzzi JL. Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates. J Am Coll Cardiol. 2022 08 09; 80(6):565-578. PMID: 35926929; PMCID: PMC9396356.
    Citations: 4     Fields:    Translation:Humans
  7. Mohebi R, Murphy S, Jackson L, McCarthy C, Abboud A, Murtagh G, Gawel S, Miksenas H, Gaggin H, Januzzi JL. Biomarker prognostication across Universal Definition of Heart Failure stages. ESC Heart Fail. 2022 12; 9(6):3876-3887. PMID: 35942508; PMCID: PMC9773759.
    Citations: 1     Fields:    Translation:Humans
  8. Mohebi R, Karimi Galougahi K, Ali ZA. Reply: Contrast-Associated Acute Kidney Injury After Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2022 06 27; 15(12):1283-1284. PMID: 35738750.
    Citations:    Fields:    Translation:Humans
  9. Mohebi R, McCarthy CP, Gaggin HK, van Kimmenade RRJ, Januzzi JL. Inflammatory biomarkers and risk of cardiovascular events in patients undergoing coronary angiography. Am Heart J. 2022 10; 252:51-59. PMID: 35753356; PMCID: PMC9336200.
    Citations:    Fields:    
  10. Mohebi R, McCarthy CP, Magaret CA, Barnes G, Rhyne RF, Peters C, Gaggin HK, Januzzi JL. Performance of a protein biomarker panel for prediction of cardiovascular events in patients with diabetes mellitus. Eur J Prev Cardiol. 2022 05 27; 29(8):e270-e271. PMID: 35258630.
    Citations:    Fields:    Translation:Humans
  11. Karimi Galougahi K, Mohebi R, Chertow GM, Ali ZA. Reply: Alterations in Practice Because of Contrast-Associated Acute Kidney Injury Following PCI: An Example of "Renalism". JACC Cardiovasc Interv. 2022 05 23; 15(10):1093-1094. PMID: 35589242.
    Citations:    Fields:    Translation:Humans
  12. Mohebi R, van Kimmenade R, McCarthy C, Gaggin H, Mehran R, Dangas G, Januzzi JL. A Biomarker-Enhanced Model for Prediction of Acute Kidney Injury and Cardiovascular Risk Following Angiographic Procedures: CASABLANCA AKI Prediction Substudy. J Am Heart Assoc. 2022 05 17; 11(10):e025729. PMID: 35574956; PMCID: PMC9238548.
    Citations:    Fields:    Translation:Humans
  13. Mohebi R, Jackson L, McCarthy CP, Murtagh G, Murphy SP, Abboud A, Miksenas H, Gaggin HK, Januzzi JL. Relation of High-Sensitivity Cardiac Troponin I and Obstructive Coronary Artery Disease in Patients Without Acute Myocardial Infarction. Am J Cardiol. 2022 06 15; 173:16-24. PMID: 35361478.
    Citations:    Fields:    Translation:Humans
  14. Mohebi R, Karimi Galougahi K, Garcia JJ, Horst J, Ben-Yehuda O, Radhakrishnan J, Chertow GM, Jeremias A, Cohen DJ, Cohen DJ, Maehara A, Mintz GS, Chen S, Redfors B, Leon MB, Stuckey TD, Rinaldi MJ, Weisz G, Witzenbichler B, Kirtane AJ, Mehran R, Dangas GD, Stone GW, Ali ZA. Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: An ADAPT-DES Substudy. JACC Cardiovasc Interv. 2022 04 11; 15(7):753-766. PMID: 35305904.
    Citations: 1     Fields:    Translation:Humans
  15. Mohebi R, Januzzi JL. Cardiovascular benefit of SGLT2 inhibitors. Crit Rev Clin Lab Sci. 2022 05; 59(3):142-155. PMID: 34784839.
    Citations:    Fields:    Translation:Humans
  16. Januzzi JL, Mohebi R. Obesity-Mediated Disruption of Natriuretic Peptide-Blood Pressure Rhythms. J Am Coll Cardiol. 2021 05 11; 77(18):2304-2306. PMID: 33958127.
    Citations: 1     Fields:    Translation:Humans
  17. Redfors B, Mohebi R, Giustino G, Chen S, Selker HP, Thiele H, Patel MR, Udelson JE, Ohman EM, Eitel I, Granger CB, Maehara A, Ali ZA, Ben-Yehuda O, Stone GW. Time Delay, Infarct Size, and Microvascular Obstruction After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction. Circ Cardiovasc Interv. 2021 02; 14(2):e009879. PMID: 33440999.
    Citations: 3     Fields:    Translation:Humans
  18. Mohebi R, Chen Q, Hegele RA, Rosenson RS. Failure of cosegregation between a rare STAP1 missense variant and hypercholesterolemia. J Clin Lipidol. 2020 Sep - Oct; 14(5):636-638. PMID: 32828708.
    Citations: 1     Fields:    Translation:Humans
  19. Mohebi R, Rosenson R. Statins in the perioperative period. F1000Res. 2019; 8. PMID: 31131090.
    Citations: 2     Fields:    Translation:Humans
  20. Popovic D, Martic D, Djordjevic T, Pesic V, Guazzi M, Myers J, Mohebi R, Arena R. Oxygen consumption and carbon-dioxide recovery kinetics in the prediction of coronary artery disease severity and outcome. Int J Cardiol. 2017 Dec 01; 248:39-45. PMID: 28689985.
    Citations: 3     Fields:    Translation:Humans
  21. Mohebi R, Jehan A, Grober A, Froelicher V. Percentile categorization of QT interval as an approach for identifying adult patients at risk for cardiovascular death. Heart Rhythm. 2017 08; 14(8):1210-1216. PMID: 28495651.
    Citations:    Fields:    Translation:Humans
  22. Mohebi R, Simforoosh A, Tohidi M, Azizi F, Hadaegh F. Obesity Paradox and Risk of Mortality Events in Chronic Kidney Disease Patients: A Decade of Follow-up in Tehran Lipid and Glucose Study. J Ren Nutr. 2015 Jul; 25(4):345-50. PMID: 25680526.
    Citations: 9     Fields:    Translation:Humans
  23. Mohebi R, Mohebi A, Sheikholeslami F, Azizi F, Hadaegh F. Wrist circumference as a novel predictor of hypertension and cardiovascular disease: results of a decade follow up in a West Asian cohort. J Am Soc Hypertens. 2014 Nov; 8(11):800-7. PMID: 25455005.
    Citations: 11     Fields:    Translation:Humans
  24. Mohebi R, Mohebi A, Ghanbarian A, Momenan A, Azizi F, Hadaegh F. Is systolic blood pressure below 150 mm Hg an appropriate goal for primary prevention of cardiovascular events among elderly population? J Am Soc Hypertens. 2014 Jul; 8(7):491-7. PMID: 25064771.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  25. Nejat A, Mirbolouk M, Mohebi R, Hasheminia M, Tohidi M, Saadat N, Azizi F, Hadaegh F. Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study. Clin Biochem. 2014 Sep; 47(13-14):1239-44. PMID: 24657509.
    Citations: 16     Fields:    Translation:Humans
  26. Moghaddam MM, Mohebi R, Hosseini F, Lotfaliany M, Azizi F, Saadat N, Hadaegh F. Distribution of ideal cardiovascular health in a community-based cohort of Middle East population. Ann Saudi Med. 2014 Mar-Apr; 34(2):134-42. PMID: 24894782.
    Citations: 14     Fields:    Translation:Humans
  27. Hadaegh F, Hasheminia M, Lotfaliany M, Mohebi R, Azizi F, Tohidi M. Incidence of metabolic syndrome over 9 years follow-up; the importance of sex differences in the role of insulin resistance and other risk factors. PLoS One. 2013; 8(9):e76304. PMID: 24086723.
    Citations: 28     Fields:    Translation:Humans
  28. Mohebi R, Bozorgmanesh M, Azizi F, Hadaegh F. Effects of obesity on the impact of short-term changes in anthropometric measurements on coronary heart disease in women. Mayo Clin Proc. 2013 May; 88(5):487-94. PMID: 23540294.
    Citations: 1     Fields:    Translation:Humans
  29. Tohidi M, Mohebi R, Cheraghi L, Hajsheikholeslami F, Aref S, Nouri S, Azizi F, Hadaegh F. Lipid profile components and incident cerebrovascular events versus coronary heart disease; the result of 9 years follow-up in Tehran Lipid and Glucose Study. Clin Biochem. 2013 Jun; 46(9):716-21. PMID: 23531403.
    Citations: 7     Fields:    Translation:Humans
  30. Mohebi R, Bozorgmanesh M, Sheikholeslami F, Azizi F, Hadaegh F. Contribution of glomerular filtration rate to 10-year cardiovascular and mortality risk among hypertensive adults: Tehran lipid and glucose study. J Clin Hypertens (Greenwich). 2013 May; 15(5):350-8. PMID: 23614851.
    Citations: 2     Fields:    Translation:Humans
  31. Bozorgmanesh M, Ghoreishian H, Mohebi R, Azizi F, Hadaegh F. Sex-specific predictors of the prehypertension-to-hypertension progression: community-based cohort of a West-Asian population. Eur J Prev Cardiol. 2014 Aug; 21(8):956-63. PMID: 23478742.
    Citations: 5     Fields:    Translation:Humans
  32. Bozorgmanesh M, Hadaegh F, Mohebi R, Ghanbarian A, Eskandari F, Azizi F. Diabetic population mortality and cardiovascular risk attributable to hypertension: a decade follow-up from the Tehran Lipid and Glucose Study. Blood Press. 2013 Oct; 22(5):317-24. PMID: 23458066.
    Citations: 3     Fields:    Translation:Humans
  33. Hadaegh F, Jahangiri Noudeh Y, Tohidi M, Vatankhah N, Khalili D, Mohebi R, Azizi F. Change in general and central adiposity measures in prediction of incident dysglycemia; Tehran Lipid and Glucose Study. Prev Med. 2012 Dec; 55(6):608-12. PMID: 23046898.
    Citations: 3     Fields:    Translation:Humans
  34. Fahimfar N, Khalili D, Mohebi R, Azizi F, Hadaegh F. Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran. BMC Neurol. 2012 Oct 02; 12:117. PMID: 23031547.
    Citations: 18     Fields:    Translation:Humans
  35. Tohidi M, Hasheminia M, Mohebi R, Khalili D, Hosseinpanah F, Yazdani B, Nasiri AA, Azizi F, Hadaegh F. Incidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort. PLoS One. 2012; 7(9):e45304. PMID: 23028919.
    Citations: 44     Fields:    Translation:Humans
  36. Hatami M, Tohidi M, Mohebi R, Khalili D, Azizi F, Hadaegh F. Adolescent lipoprotein classifications according to National Health and Nutrition Examination Survey (NHANES) vs. National Cholesterol Education Program (NCEP) for predicting abnormal lipid levels in adulthood in a Middle East population. Lipids Health Dis. 2012 Aug 31; 11:107. PMID: 22937812.
    Citations: 3     Fields:    Translation:Humans
  37. Hadaegh F, Mohebi R, Cheraghi L, Tohidi M, Moghaddam NB, Bozorogmanesh M, Sheikholeslami F, Azizi F. Do different metabolic syndrome definitions predict cerebrovascular events and coronary heart disease independent of their components?: 9 years follow-up of the tehran lipid and glucose study. Stroke. 2012 Jun; 43(6):1669-71. PMID: 22382161.
    Citations: 11     Fields:    Translation:Humans
  38. Hadaegh F, Mohebi R, Bozorgmanesh M, Saadat N, Sheikholeslami F, Azizi F. Electrocardiographic abnormalities improve classification of coronary heart disease risk in women: Tehran Lipid and Glucose Study. Atherosclerosis. 2012 May; 222(1):110-5. PMID: 22385984.
    Citations:    Fields:    Translation:Humans
  39. Hadaegh F, Hatami M, Mohebi R, Hasheminia M, Bozorgmanesh M, Sheikholeslami F, Azizi F. Electrocardiography-defined silent CHD and risk of cardiovascular events among diabetic patients in a Middle Eastern population. Eur J Prev Cardiol. 2012 Dec; 19(6):1227-33. PMID: 22013153.
    Citations: 2     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Mohebi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (157)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.